Clinical Trials for AskBio

Explore 10 clinical trials worldwide

Showing 1-10 of 10 trials

Active filters:Status: Recruiting, Active, not recruiting, Enrolling by invitation, Not yet recruitingSponsor: AskBio

Clinical Trials (10)

NCT07215403
Prescriptive Infusion Algorithm (PIA)
PHASE2Not yet recruiting
12 participants
Started: May 1, 2026 · Completed: Mar 1, 2028
1 condition2 sponsors0 locations
NCT07081841
AB-1005 Long-Term Follow-up Study
N/AEnrolling by invitation
132 participants
Started: Sep 4, 2025 · Completed: Mar 30, 2038
2 conditions1 sponsor2 locations
NCT06285643
A Study of AAV2-GDNF in Adults With Moderate Parkinson's Disease (REGENERATE-PD)
PHASE2Recruiting
87 participants
Started: Jun 11, 2024 · Completed: Nov 30, 2027
1 condition2 sponsors39 locations
NCT05598333
Phosphatase Inhibition by Intracoronary Gene Therapy in Subjects With Non-Ischemic NYHA Class III Heart Failure
PHASE2Recruiting
150 participants
Started: Oct 20, 2023 · Completed: Dec 31, 2030
1 condition1 sponsor46 locations
NCT05230459
A Study to Evaluate the Safety of AB-1003 (Previously LION-101) in Subjects With Genetic Confirmation of LGMD2I/R9 (Part1)
PHASE1/PHASE2Recruiting
10 participants
Started: May 15, 2023 · Completed: Dec 31, 2028
9 conditions1 sponsor6 locations
NCT05541627
A Study to Evaluate AB-1001 Striatal Administration in Adults With Early Manifest Huntington's Disease
PHASE1/PHASE2Active, not recruiting
5 participants
Started: Oct 12, 2022 · Completed: Apr 30, 2028
1 condition1 sponsor1 location
NCT05699460
Pre-Gene Therapy Study in Parkinson's Disease and Multiple System Atrophy
N/AActive, not recruiting
150 participants
Started: Sep 29, 2022 · Completed: Nov 30, 2025
3 conditions1 sponsor11 locations
NCT04167540
GDNF Gene Therapy for Parkinson's Disease
PHASE1Active, not recruiting
11 participants
Started: Apr 1, 2020 · Completed: Jun 30, 2027
1 condition3 sponsors3 locations
NCT04179643
AB-1002 in Patients With Class III Heart Failure
PHASE1Active, not recruiting
17 participants
Started: Nov 20, 2019 · Completed: Sep 30, 2026
9 conditions1 sponsor4 locations
NCT03533673
AAV2/8-LSPhGAA (ACTUS-101) in Late-Onset Pompe Disease
PHASE1/PHASE2Active, not recruiting
7 participants
Started: Dec 17, 2018 · Completed: Mar 31, 2026
1 condition1 sponsor1 location